Shareholder Information
Investor Overview
NovaBay is focused on developing innovative product candidates targeting the treatment or prevention of a wide range of infections in hospital and community environments. Many of these infections have become increasingly difficult to treat because of the rapid increase in infectious microbes that have become resistant to current drugs. Our in vitro and in vivo tests have demonstrated that our compounds kill a wide range of bacteria, viruses and other infection causing microbes, including those that are resistant to multiple antibiotics. We are developing hospital indications ourselves and have partnered certain other indications with Alcon, the world's leading eye care company, and with Galderma S.A., a world leader in dermatology.
Transfer Agent
The transfer agent and registrar for our common stock is Computershare Trust Company, N.A. with the following contact information:
For standard US postal mail
Computershare Trust Company, N.A.
Po Box 43070
Providence, RI 02940-3070
For overnight/express delivery
Computershare Trust Company, N.A.
250 Royall Street
Canton, MA 02021
For DWAC instructions provided to brokers
FAST Transfer Agent number – 50173
Telephone and Fax
Toll free in the US +1 800 962 4284
Telephone +1 303-262-0600
Fax +1 303-262-0700
Website
www.computershare.com
eMail inquiries
web.queries@computershare.com
Theresa Granados at NovaBayPharmaceuticals, Inc. at:
(510) 899-8870
